Pentamaster diversifying into medical device business


Pentamaster chairman CB Chuah (pic) told StarBiz that the group was now in the process of submitting application to get approvals from the US-based Food & Drugs Agency (FDA) and Malaysian Drug Agency (MDA) for the business.

GEORGE TOWN: Semiconductor test equipment maker Pentamaster Corp Bhd is investing over RM100mil over the next three years in a medical device plant as the company seeks to diversify into the medical device business to broaden its revenue base.

Group chairman CB Chuah told StarBiz that the group was now in the process of submitting application to get approvals from the US-based Food & Drugs Agency (FDA) and Malaysian Drug Agency (MDA) for the business.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Metro Healthcare edges higher on ACE Market debut
Bursa Malaysia set to hold firm ahead of GDP data
Malaysia removed from US currency monitoring list
Tengku Zafrul: Longer term pain from US-China rift
Ringgit opens marginally higher against us dollar
Trading ideas: Bumi Armada, MISC, Sunway REIT, MR DIY, Teo Seng, Berjaya Food, LBS Bina
KIP-REIT buys retail asset in Perak
Brighter outlook for MMHE on diversification path
Stronger second half seen for Hap Seng Plantations
Senate probes unauthorised transactions

Others Also Read